The clinical presentation and positive DAT confirm immune-mediated hemolysis. The next step is to characterize the antibody involved.
| Investigation | Purpose | Specificity | Clinical Use |
|---|---|---|---|
| Flow cytometry (anti-IgG/IgM) | Identify antibody class on RBC surface | High | Classify AIHA subtype, guide therapy |
| Indirect antiglobulin test (IAT) | Detect free antibodies in serum | Moderate | Screening, not classification |
| Elution test | Recover antibodies from RBC surface | Moderate | Identify antibody specificity (alloimmunization) |
| Osmotic fragility | Assess RBC membrane integrity | Low | Hereditary spherocytosis, not immune hemolysis |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →